| Literature DB >> 26816059 |
M Amling1, R Oheim2,3, F Barvencik2.
Abstract
Secondary fracture prevention is of paramount importance in the clinical management of patients with hip fractures. However, in contrast to the excellent surgical care provided to these patients in the Western hemisphere and despite good medical options, causative treatment of the underlying osteopathy causing skeletal fragility remains an unmet medical need that urgently needs to be improved. This calls for a concerted action between orthopedic/trauma surgeons and osteologists, as outstanding hospitals not only treat fragility fractures, but also prevent fractures from recurring. Aiming for a holistic hip fracture approach, in this work we highlight aspects of (a) improved risk assessment and differential diagnosis, (b) optimized basic medical care, and (c) options for individualized, specific medical intervention within a realistic framework of current medical options and future perspectives.Entities:
Keywords: Bisphosphonates; Bone structure; Cathepsin k; DXA; Denosumab; Fragility fractures; Hypochlorhydria; Osteoporosis; PPI; Risk assessment; Secondary fracture prevention; Sklerostin; Strontium ranelate; Teriparatide; Vitamin D; XtremeCT
Year: 2014 PMID: 26816059 DOI: 10.1007/s00068-014-0374-y
Source DB: PubMed Journal: Eur J Trauma Emerg Surg ISSN: 1863-9933 Impact factor: 3.693